HepatologyNews.net

Hepatology Xagena

Search results for "Hepatitis C"

More than half of 61 children and adolescents infected with chronic hepatitis C achieved a sustained viral response after treatment with Peginterferon-alfa-2b ( Peg-Intron ) and Ribavirin ( Rebetol ). ...


The FDA ( Food and Drug Administration ) approved Pegasys ( Peginterferon alfa-2a ) for the treatment of chronic hepatitis B ( CHB ). Pegasys is the first and only pegylated Interferon approved fo ...


No medical treatment exists for nonalcoholic steatohepatitis ( NASH ), inflammation of the liver associated with the accumulation of fat in the liver. Recent studies indicate that NASH can result i ...


A Phase Ib clinical trial showed that the oral hepatitis C virus ( HCV ) protease inhibitor, VX-950 ( Telaprevir ), for 5 and 14 days was well-tolerated in both healthy volunteers and in patients with ...


Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body’s immune system during infe ...


A study assessed the incidence and risk factors associated with hepatitis C infection in rural Egypt. The prevalence of antibodies to hepatitis C virus ( HCV ) in Egypt is among the highest in the ...


Patients with the most common form of hepatitis B in the United States who are treated with Pegasys ( Peginterferon alfa-2a ) are more likely to achieve a sustained response than those treated with La ...


Two studies on hepatitis C ( HCV ) patients who underwent liver transplants examined a potential biomarker that could be used to predict who might develop hepatic fibrosis, a formation of scar-like ti ...


Nearly half of 118 children with chronic Hepatitis C virus ( HCV ) treated with a combination of Interferon-alpha-2b ( Intron A ) and an optimized dose of Ribavirin ( Rebetol ) achieved sustained vira ...


A study in Japan examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower l ...


Liver transplant patients with hepatitis C virus ( HCV ) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine ( Sandimmun Neoral ) along with Int ...


When a diseased liver is removed from a patient with hepatitis C (HCV), serum viral levels plummet. However, after receiving a healthy liver transplant, virus levels rebound and can surpass pre-tran ...


A study on HIV patients who also had hepatitis B virus ( HBV ) found that better outcomes are possible if they are referred early for transplant and treated with a combination of drugs for HBV. It i ...


Drinking coffee may be related to a reduced risk of developing the liver disease alcoholic cirrhosis. Cirrhosis progressively destroys healthy liver tissue and replaces it with scar tissue. Virus ...


Obese patients chronically infected with the hepatitis C virus ( HCV ) and treated with combination drug therapy may have better outcomes if the underlying abnormalities caused by excessive fat tissue ...